Sophie Kornowski Ph.D

Sophie Kornowski Ph.D General Information

Biography

Dr. Sophie Kornowski serves as Board Member at Alladapt Immunotherapeutics. She served as Board Member, Advisor to the Syngenta Group Board & Member of Compensation Committee & Sustainability Committee at Syngenta. She serves as Board Member at Crossover, Teal Bio, and Mahana Therapeutics. She also serves as Strategic Advisor at Nacre Capital. She served as a Senior Partner at Gurnet Point Capital. She serves as Chairperson at Corium International. She also serves as Chief Executive Officer and Co-Chairman at Boston Pharmaceuticals, Syngenta, Crossover Health, Naveris, and Alladapt Immunotherapeutics. She also spent 11 years in various leadership roles at Merck in the United States, France, and Israel. She spent the early years of her career at Abbott and Sanofi, in France and the United States. She serves as Board Member at SpoonfulOne. She joined Gurnet Point Capital in 2018 from Roche, where she was Executive Vice-President of Roche Partnering. In that role, she focused on establishing external partnerships with biotechnology and research institutions worldwide for Roche Holding AG, one of the world's largest healthcare companies. While she was Head of Partnering at Roche, she and her team completed over 50 deals per year. Prior to that, she spent five years leading Roche's major affiliate in France. She was also a member of Roche's Extended Global Executive Committee. In addition to her contributions at Roche, she gathered 11 years of experience in various leadership roles at Merck in the United States, France, and Israel. She spent the early years of her career at Abbott and Sanofi, both in France and in the United States. She served as Board Member at Stallergenes Greer. She served as Board Member at SpoonfulONE.